Beam Therapeutics Inc. License Agreements
9 Contracts & Agreements
- Amendment to License Agreement between The Broad Institute, Inc. and Beam Therapeutics Inc., dated May 31, 2024 (Filed With SEC on August 6, 2024)
- First Amendment to License Agreement, between The Broad Institute, Inc. and Blink Therapeutics Inc., dated September 4, 2018 (Filed With SEC on March 15, 2021)
- Amendment No. 2 to License Agreement, between the President and Fellows of Harvard College and Beam Therapeutics Inc., dated March 27, 2020 (Filed With SEC on March 15, 2021)
- Amendment No. 1 to License Agreement, between the President and Fellows of Harvard College and Beam Therapeutics Inc., dated December 12, 2017 (Filed With SEC on March 15, 2021)
- License Agreement, by and between The Broad Institute, Inc. and Blink Therapeutics Inc., dated as of May 9, 2018 (Filed With SEC on September 27, 2019)
- License Agreement, by and between Bio Palette Co., Ltd. and Beam Therapeutics Inc., dated as of March 27, 2019 (Filed With SEC on September 27, 2019)
- License Agreement, by and between Editas Medicine, Inc. and Beam Therapeutics Inc., dated as of May 9, 2018 (Filed With SEC on September 27, 2019)
- License Agreement, by and between the President and Fellows of Harvard College and Beam Therapeutics Inc., dated as of June 27, 2017 (Filed With SEC on September 27, 2019)
- License Agreement, by and between MIL 21E, LLC and Beam Therapeutics Inc., dated as of June 25, 2019 (Filed With SEC on September 27, 2019)
